Dr. Anderson on the GRIFFIN Study With D-RVd in Multiple Myeloma
April 18th 2020Larry Anderson, MD, PhD, discusses the phase II GRIFFIN trial examining the addition of daratumumab (Darzalex) to lenalidomide (Revlimid), bortezomib (Velcade), and dexamethasone (D-RVd) in patients with multiple myeloma.
Read More